MISSOURI VALLEY CANCER CONSORTIUM CCOP

密苏里河谷癌症协会 CCOP

• 批准号: 2712699
• 负责人: JAMES A MAILLIARD
• 金额: $ 37.98万
• 依托单位: CANCER ALLIANCE OF NEBRASKA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-09-30 至 2002-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2712699
• 关键词: behavioral /social science research tag; breast neoplasms; cancer prevention; clinical research; community health services; cooperative study; data management; human subject; human therapy evaluation; neoplasm /cancer education; neoplasm /cancer therapy; patient /disease registry; prostate neoplasms

DESCRIPTION: (Applicant's Description) The Missouri Valley Cancer Consortium (MVCC) is a multi-component community-based cancer research effort based in Omaha and Lincoln, Nebraska. The catchment area includes western Iowa and east-central Nebraska. The 1990 population was about 1.2 million. The MVCC is the third largest accruer of patients to cancer treatment protocols and the second largest to cancer control protocols in the North Central Cancer Treatment Group. The four main components of the MVCC are Alegent Health Bergan Mercy Medical Center, Alegent Health Immanuel Medical Center, Lincoln Cancer Center, and Creighton University. These institutions have had an established research program with the North Central Cancer Treatment Group (NCCTG) since 1983. Numerous investigators (52) participate and are responsible for over 3200 new cancer patients annually. Over the past 2 years of the previous funding period, these investigators have entered 201.1 and 223.4 patients on NCI-approved cancer treatment and control trials, respectively. The proposed principal and associate principal investigators of the MVCC are currently directing the conduct of the Breast Cancer Prevention Trial and the Prostate Cancer Prevention Trial (837 enrolled and 639 randomized for the state of Nebraska. Previous research base affiliations with NCCTG, ECOG, and NSABP would continue with the addition of RTOG and GOG and enable the future support of this high level of accrual as a NCI-funded CCOP.

描述：(应聘者描述)密苏里州山谷癌症 MVCC是一个以社区为基础的多组分癌症研究组织 总部设在内布拉斯加州奥马哈和林肯的努力。集水区包括 爱荷华州西部和内布拉斯加州中东部。1990年的人口约为1.2人 百万美元。 MVCC是癌症治疗患者的第三大收入者 协议和北方第二大癌症控制协议 中央癌症治疗组。MVCC的四个主要组成部分是 伯尔根仁慈医疗中心，仁慈医疗中心 中心、林肯癌症中心和克雷顿大学。这些机构 已经制定了针对中北部癌症的研究计划 治疗组(NCCTG)自1983年以来。众多调查人员(52人)参与 每年负责3200多名新的癌症患者。超过了 在前一个资助期的过去两年里，这些调查人员 进入201.1和223.4名患者接受国家癌症研究所批准的癌症治疗和 分别为对照试验。建议的校长和联营公司 MVCC的首席调查人员目前正在指导 乳腺癌预防试验和前列腺癌预防试验 (837人登记，639人随机进入内布拉斯加州。上一首 与NCCTG、ECOG和NSABP的研究基地关系将继续 RTOG和GOG的加入，使后市能够支撑这一高点 作为NCI资助的CCOP的应计水平。